DANA-FARBER CANCER INSTITUTE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1947-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.dana-farber.org/
Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia
Phase 1
- Conditions
- Fanconi's Anemia
- First Posted Date
- 2000-08-04
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 21
- Registration Number
- NCT00006127
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath